• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

What to make of Freshworks’ first IPO price range

September 13, 2021 by David Barret Leave a Comment

Two major private tech companies announced IPO price ranges this morning, with Toast targeting a market value of nearly $18 billion at the top end of its range and Freshworks looking to price its equity between $28 and $32 per share. TechCrunch calculates that the company would be worth around $8.9 billion at $32 per share, not employing a fully diluted share count.

Inclusive of shares represented by fully vested options and the like, Freshworks’ valuation could reach $9.6 billion, Renaissance Capital reports.

Unlike Toast, with a revenue mix including four distinct products, Freshworks is a more straightforward software company. That means we can do much more interesting work to understand its valuation. So, this morning, let’s unpack how Freshworks is considering valuing itself in its IPO at its present range, look at some market comps, and come to a conclusion regarding whether or not we expect the unicorn to raise its valuation before it floats.

Lies, damned lies and revenue multiples

As a refresher, in the first half of 2021 (Q1 and Q2), Freshworks posted revenues of $168.9 million. That annualizes to $337.9 million, thanks to numerical rounding.

At a valuation of $9.6 billion — recall that simple IPO valuations for the company and lower share-price points from its IPO range generate lower valuations and therefore more conservative multiples than what we’ll be discussing here — Freshworks would be worth 28.4x its current revenue run rate, set during H1 2021.

Source Link What to make of Freshworks’ first IPO price range

David Barret
David Barret

Related posts:

  1. Chevron braces for activist challenge; meets Engine No.1 representatives- WSJ
  2. Acquired by Mercedes-Benz, YASA’s revolutionary electric motor is set for big things
  3. European stocks mark worst fall in 2 weeks on U.S. job jitters
  4. Tennis – U.S. Open order of play on Saturday

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • IFLScience The Big Questions: Why Do People Believe In The Paranormal?
  • What Is “Japanese Walking”, And Should You Be Doing It?
  • AI Chatbots Found To Violate Ethical Standards When It Comes To Mental Health Discussions
  • Finding The Last Saolas: The Hunt For One Of The World’s Rarest Mammals Is On
  • This Is What People Actually See When They Have A Near-Death Experience
  • Bird Flu Is Making Headlines Once Again: What’s The Current Situation?
  • A Whale Protected A Scientist From A Huge Shark. A Year And 15 Days Later, They Were Reunited
  • This 600-Year-Old Inca Building Was Designed For An Incredible Acoustic Reason
  • Up To 90 Percent Of People Have This Health Condition. Just As Many Have Never Heard Of It
  • A Forgotten 19th Century “Vortex” Model Of The Atom May Help Explain Why The Universe Exists At All
  • Potential Environmental Trigger For Autism Identified, But Don’t Expect MAHA Action
  • Interstellar Object 3I/ATLAS’s Tail Appears To Have Changed Direction
  • “It Seemingly Put On An Otherworldly Show”: Watch As This Beautiful Deep-Sea Octopus Glides Gracefully Through The Ocean
  • Have You Heard About America’s Government Cheese Caves? They’ve Got Over 600 Million Kilograms Of The Stuff Stashed Away
  • There Could Be A Surprising Health Benefit To Having Gray Hair
  • New Answer To The Fermi Paradox? Cognitive Horizon Hypothesis May Explain Why Aliens Haven’t Contacted Us
  • What Happened When Patient B-19 Was Given A Brain Stimulation Device And A Button?
  • The Ice Age Squirrel That Enabled A Plant’s Resurrection 31,800 Years Later
  • The First Video Game Came Long Before Pong And Was Invented By A Manhattan Project Physicist
  • Monster Hoaxes In The Age Of AI: Seeing Isn’t Believing Anymore
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version